Advagen Pharma Europe OÜ

RegisteredNo tax debt
CONTENTS
Revenue2023
355k €
Profit2023
6,715 €
Employees (report, FTE)2023
0
Equity2023
6,715 €

Main data

Registration code
VAT number
Legal form
Founded
Address
View on map →
Primary activity
Capital

Contacts

E-mail
varun@rubicon.co.in

Management board and persons on card

Osaühingut võib kõikide tehingute tegemisel esindada iga juhatuse liige.

Shareholders

  • Rubicon Research Limited100.00% · 0.01 €
    Shareholder · Ainuomand

Other persons (off-card)

  • Rubicon Research Private LimitedFounder

Areas of activity

Ravimpreparaatide tootmine21201

Tax debt

The Estonian Tax and Customs Board publishes debts from EUR 100. The total includes deferred and disputed amounts. Disputed debt with suspended enforcement is not published. Only legal persons are published.
No tax debt
Data as of 14.10.2026
Source: Estonian Tax and Customs Board (CC BY-SA 3.0) · Check in the EMTA query

Annual reports

Rulings